Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

BAX PEER ANALYSIS

Baxter International Inc — metric-by-metric comparison with peers and the industry median

BAXBaxter International Inc

🇺🇸 USA · US · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Instruments & Supplies

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
BAXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
BAX-26.6%FPH-1.9%RMD-20.9%ANN+6.3%EL-24.3%
Year-to-Date (YTD)
BAX+18.3%FPH+1.1%RMD-13.6%ANN-6.0%EL-34.5%
1-Year
Split-adjusted
BAX-26.6%ALGN-4.3%SOLV-0.7%COO-0.9%ATR-20.6%RGEN+11.0%
Year-to-Date (YTD)
BAX+18.3%ALGN+20.6%SOLV-1.6%COO-11.4%ATR+4.1%RGEN-13.7%

Key Metric Comparison

P/E

Lower is better
BAX—FPH41.60RMD20.60ANN24.22EL34.99Median 34.99

ROE

Higher is better
BAX-16.7%FPH23.3%RMD25.2%ANN7.2%EL5.8%Median 2.3%

Net Margin

Higher is better
BAX-9.7%FPH20.0%RMD27.4%ANN6.7%EL8.1%Median 3.9%

Revenue Growth

Higher is better
BAX5.1%FPH4.8%RMD10.5%ANN11.4%EL7.5%Median 6.4%

P/E

Lower is better
BAX—ALGN31.38SOLV9.55COO60.05ATR21.13RGEN155.96Median 34.99

ROE

Higher is better
BAX-16.7%ALGN10.8%SOLV34.8%COO2.9%ATR15.0%RGEN2.5%Median 2.3%

Net Margin

Higher is better
BAX-9.7%ALGN10.5%SOLV17.3%COO5.6%ATR10.0%RGEN6.7%Median 3.9%

Revenue Growth

Higher is better
BAX5.1%ALGN2.9%SOLV-0.6%COO6.1%ATR8.9%RGEN18.2%Median 6.4%

All Metrics

Valuation
MetricBAXFPHRMDANNELInd. Median
P/E—41.6020.60●24.2234.9934.99
P/B1.929.154.791.66●2.082.97
EV/EBITDA26.1523.4714.0012.55●14.0414.66
P/S1.03●8.335.631.592.842.81
Financial Health
MetricBAXFPHRMDANNELInd. Median
Current Ratio1.852.313.01●2.360.992.40
Debt/Equity160.3%6.9%●13.0%46.2%37.0%34.8%
NetDebt/EBITDA10.39-0.39●-0.382.101.661.44
Profitability
MetricBAXFPHRMDANNELInd. Median
Net Margin-9.7%20.0%27.4%●6.7%8.1%3.9%
ROE-16.7%23.3%25.2%●7.2%5.8%2.3%
ROA-5.3%17.3%18.6%●4.2%3.6%1.5%
EBITDA Margin6.5%34.9%39.1%●15.2%23.0%13.8%
Growth + Dividend
MetricBAXFPHRMDANNELInd. Median
Rev. Growth5.1%4.8%10.5%11.4%●7.5%6.4%
NI Growth—-11.6%15.9%23.8%●-1.8%14.0%
Div. Yield1.7%1.6%8.0%●1.7%2.3%1.7%
Payout-24.2%53.9%22.4%53.2%0.0%22.4%
Valuation
MetricBAXALGNSOLVCOOATRRGENInd. Median
P/E—31.389.55●60.0521.13155.9634.99
P/B1.923.252.751.72●3.113.812.97
EV/EBITDA26.1513.796.61●19.0311.2045.8914.66
P/S1.03●3.291.663.352.1110.502.81
Financial Health
MetricBAXALGNSOLVCOOATRRGENInd. Median
Current Ratio1.851.391.071.271.669.20●2.40
Debt/Equity160.3%2.8%●102.2%29.9%53.6%32.7%34.8%
NetDebt/EBITDA10.39-1.04●1.642.681.41-0.561.44
Profitability
MetricBAXALGNSOLVCOOATRRGENInd. Median
Net Margin-9.7%10.5%17.3%●5.6%10.0%6.7%3.9%
ROE-16.7%10.8%34.8%●2.9%15.0%2.5%2.3%
ROA-5.3%6.9%10.0%●1.9%8.0%1.8%1.5%
EBITDA Margin6.5%22.2%33.3%●20.5%21.6%22.6%13.8%
Growth + Dividend
MetricBAXALGNSOLVCOOATRRGENInd. Median
Rev. Growth5.1%2.9%-0.6%6.1%8.9%18.2%●6.4%
NI Growth—5.0%277.8%●-43.1%4.4%—14.0%
Div. Yield1.7%●———1.5%—1.7%
Payout-24.2%———31.5%—22.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BAX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.